Published in J Immunol on April 01, 2006
Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med (2007) 2.85
Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev (2011) 1.87
The connection between C-reactive protein and atherosclerosis. Ann Med (2008) 1.29
Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE). J Nutr (2015) 1.20
Pattern recognition by pentraxins. Adv Exp Med Biol (2009) 1.19
C-reactive protein collaborates with plasma lectins to boost immune response against bacteria. EMBO J (2007) 1.19
Discrimination between host and pathogens by the complement system. Vaccine (2008) 1.11
Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology (2010) 1.10
Identification of acidic pH-dependent ligands of pentameric C-reactive protein. J Biol Chem (2010) 0.96
Human C-reactive protein protects mice from Streptococcus pneumoniae infection without binding to pneumococcal C-polysaccharide. J Immunol (2007) 0.95
Pathogen recognition by the long pentraxin PTX3. J Biomed Biotechnol (2011) 0.94
Requirement for complement in antibody responses is not explained by the classic pathway activator IgM. Proc Natl Acad Sci U S A (2011) 0.90
The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection. Endocr Metab Immune Disord Drug Targets (2008) 0.89
Exposing a hidden functional site of C-reactive protein by site-directed mutagenesis. J Biol Chem (2011) 0.86
Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis. J Biol Chem (1992) 0.85
The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infection. J Biol Chem (2012) 0.81
C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms. Infect Immun (2015) 0.79
Anatomical site-specific contributions of pneumococcal virulence determinants. Pneumonia (Nathan) (2016) 0.79
A novel RBP-J kappa-dependent switch from C/EBP beta to C/EBP zeta at the C/EBP binding site on the C-reactive protein promoter. J Immunol (2007) 0.78
Neonatal infections in Saudi Arabia: association with C-reactive protein, CRP -286 (C>T>A) gene polymorphism and IgG antibodies. BMC Immunol (2013) 0.76
Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin. Antimicrob Agents Chemother (2014) 0.76
An overview of the synergy and crosstalk between pentraxins and collectins/ficolins: their functional relevance in complement activation. Exp Mol Med (2017) 0.75
Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol (1983) 7.47
Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol (2005) 3.48
Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med (1971) 3.32
The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci U S A (2002) 2.72
The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure (1999) 2.64
Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera. J Exp Med (1974) 2.47
C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J Exp Med (1981) 2.17
Phylogenetic aspects of C-reactive protein and related proteins. Ann N Y Acad Sci (1982) 2.03
The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J Biol Chem (2003) 2.02
Three dimensional structure of human C-reactive protein. Nat Struct Biol (1996) 1.87
Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J Immunol (2002) 1.87
Regulation of complement activation by C-reactive protein. Immunopharmacology (1999) 1.78
Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice. J Immunol (1982) 1.77
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice. Arterioscler Thromb Vasc Biol (2005) 1.70
Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q. J Immunol (1974) 1.68
Isolation and characterization of C-reactive protein and serum amyloid P component in the rat. Immunology (1982) 1.67
Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer? Arterioscler Thromb Vasc Biol (2005) 1.66
Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A (2005) 1.62
Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol (1995) 1.61
Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae. Infect Immun (1996) 1.60
The inhibitory effect of C-reactive protein on bacterial phosphorylcholine platelet-activating factor receptor-mediated adherence is blocked by surfactant. J Infect Dis (2002) 1.49
Interactions of C-reactive protein with the first component of human complement. J Immunol (1977) 1.45
Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. J Immunol (1999) 1.42
The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection. J Immunol (2004) 1.37
Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors. J Immunol (2002) 1.34
C-reactive protein mediates protection from lipopolysaccharide through interactions with Fc gamma R. J Immunol (2002) 1.23
Mouse C-reactive protein. Generation of cDNA clones, structural analysis, and induction of mRNA during inflammation. Biochem J (1990) 1.17
A C-reactive protein mutant that does not bind to phosphocholine and pneumococcal C-polysaccharide. J Immunol (2002) 1.14
Structural and functional anatomy of the globular domain of complement protein C1q. Immunol Lett (2004) 1.11
C-reactive protein reactivity with complement and effects on phagocytosis. Ann N Y Acad Sci (1982) 1.10
Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc Natl Acad Sci U S A (1997) 1.10
Topology and structure of the C1q-binding site on C-reactive protein. J Immunol (2001) 1.08
Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications. J Biol Chem (2004) 1.00
Regulation of phagocytic leukocyte activities by C-reactive protein. J Leukoc Biol (2000) 0.98
Complement regulation in innate immunity and the acute-phase response: inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein (CRP). Clin Exp Immunol (1998) 0.96
In vivo turnover studies of C-reactive protein. Clin Exp Immunol (1985) 0.96
Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumoniae. J Immunol (1981) 0.93
Biodistribution and clearance of 125I-labeled C-reactive protein and 125I-labeled modified C-reactive protein in CD-1 mice. Drug Metab Dispos (1998) 0.89
Lysis via the lectin pathway of complement activation: minireview and lectin pathway enhancement of endotoxin-initiated hemolysis. Immunopharmacology (1999) 0.88
Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis. J Immunol (1994) 0.88
Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis. J Biol Chem (1992) 0.85
Rat C-reactive protein activates the autologous complement system. Immunology (2003) 0.85
An intact phosphocholine binding site is necessary for transgenic rabbit C-reactive protein to protect mice against challenge with platelet-activating factor. J Immunol (2005) 0.81
Activation of rainbow trout complement by C-reactive protein. Am J Vet Res (1991) 0.79
Cloning and tissue-specific expression of the gene for mouse C-reactive protein. Biochem J (1993) 0.76
Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme. PLoS One (2011) 2.35
A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract (2003) 2.32
Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma. J Neurosurg (2014) 2.02
Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation. J Biol Chem (2007) 1.69
High HIV burden among people who inject drugs in 15 Indian cities. AIDS (2015) 1.60
Corynebacterium striatum: an underappreciated community and nosocomial pathogen. J Infect (2005) 1.37
The transcription factor CrWRKY1 positively regulates the terpenoid indole alkaloid biosynthesis in Catharanthus roseus. Plant Physiol (2011) 1.30
The connection between C-reactive protein and atherosclerosis. Ann Med (2008) 1.29
Two reactions of Haloferax volcanii RNA splicing enzymes: joining of exons and circularization of introns. RNA (2003) 1.25
C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells. J Immunol (2008) 1.21
Method for efficient fast spin echo Dixon imaging. Magn Reson Med (2002) 1.16
Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappaB on the proximal promoter. J Immunol (2005) 1.13
Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. Infect Immun (2012) 1.12
Structural and functional anatomy of the globular domain of complement protein C1q. Immunol Lett (2004) 1.11
Scavenger receptor class a plays a central role in mediating mortality and the development of the pro-inflammatory phenotype in polymicrobial sepsis. PLoS Pathog (2012) 1.10
Phosphoethanolamine-complexed C-reactive protein: a pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum. Clin Chim Acta (2008) 1.06
Lomotil dependence: a note of caution. Natl Med J India (2006) 1.06
Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine. Clin Chim Acta (2009) 1.05
Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains. Biochemistry (2006) 1.05
Structural characterization of (1-->3)-beta-D-glucans isolated from blastospore and hyphal forms of Candida albicans. Carbohydr Res (2003) 1.03
Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications. J Biol Chem (2004) 1.00
REST regulates oncogenic properties of glioblastoma stem cells. Stem Cells (2012) 1.00
Comparison of cytotoxin genotypes of Helicobacter pylori in stomach and saliva. Dig Dis Sci (2002) 1.00
Glioblastoma: imaging genomic mapping reveals sex-specific oncogenic associations of cell death. Radiology (2014) 0.96
Identification of acidic pH-dependent ligands of pentameric C-reactive protein. J Biol Chem (2010) 0.96
An endophytic/pathogenic Phoma sp. from creosote bush producing biologically active volatile compounds having fuel potential. FEMS Microbiol Lett (2011) 0.95
Sepsis and meningitis due to Capnocytophaga cynodegmi after splenectomy. Clin Infect Dis (2005) 0.95
Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist. Mol Immunol (2005) 0.94
Hematopoietic stem-progenitor cells restore immunoreactivity and improve survival in late sepsis. Infect Immun (2011) 0.93
Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure? Clin Chem (2002) 0.92
Selective and irreversible inhibitors of mosquito acetylcholinesterases for controlling malaria and other mosquito-borne diseases. PLoS One (2009) 0.91
Delivery models of opioid agonist maintenance treatment in South Asia: a good beginning. Bull World Health Organ (2013) 0.89
The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection. Endocr Metab Immune Disord Drug Targets (2008) 0.89
The phosphocholine and the polycation-binding sites on rabbit C-reactive protein are structurally and functionally distinct. Mol Immunol (2003) 0.88
Atherosclerosis-related functions of C-reactive protein. Cardiovasc Hematol Disord Drug Targets (2010) 0.87
Selective and irreversible inhibitors of aphid acetylcholinesterases: steps toward human-safe insecticides. PLoS One (2009) 0.87
A dideoxynucleotide-sensitive DNA polymerase activity characterized from endoreduplicating cells of mungbean (Vigna radiata L.) during ontogeny of cotyledons. FEBS J (2007) 0.87
Exposing a hidden functional site of C-reactive protein by site-directed mutagenesis. J Biol Chem (2011) 0.86
Scale-up of opioid substitution therapy in India: opportunities and challenges. Int J Drug Policy (2012) 0.85
MicroRNA-146a and RBM4 form a negative feed-forward loop that disrupts cytokine mRNA translation following TLR4 responses in human THP-1 monocytes. Immunol Cell Biol (2013) 0.85
Synthetic triterpenoid cyano enone of methyl boswellate activates intrinsic, extrinsic, and endoplasmic reticulum stress cell death pathways in tumor cell lines. Mol Cancer Ther (2011) 0.84
Letter to the editor: Characterization of a Grapevine leafroll-associated virus 3 from India showing incongruence in its phylogeny. Virus Genes (2012) 0.84
Oct-1 acts as a transcriptional repressor on the C-reactive protein promoter. Mol Immunol (2012) 0.84
Bioactive metabolites from an endophytic Cryptosporiopsis sp. inhabiting Clidemia hirta. Phytochemistry (2013) 0.83
Mitogen-activated protein kinase phosphatase 1 disrupts proinflammatory protein synthesis in endotoxin-adapted monocytes. Clin Vaccine Immunol (2013) 0.83
Adoptive transfer of CD34(+) cells during murine sepsis rebalances macrophage lipopolysaccharide responses. Immunol Cell Biol (2012) 0.82
Auxarthronopsis, a new genus of Onygenales isolated from the vicinity of Bandhavgarh National Park, India. IMA Fungus (2013) 0.82
T2-weighted spine imaging with a fast three-point dixon technique: comparison with chemical shift selective fat suppression. J Magn Reson Imaging (2004) 0.81
The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infection. J Biol Chem (2012) 0.81
The binding of C-reactive protein, in the presence of phosphoethanolamine, to low-density lipoproteins is due to phosphoethanolamine-generated acidic pH. Clin Chim Acta (2009) 0.81
CRP can play both pro-inflammatory and anti-inflammatory roles. Mol Immunol (2006) 0.80
Comparative one-factor-at-a-time, response surface (statistical) and bench-scale bioreactor level optimization of thermoalkaline protease production from a psychrotrophic Pseudomonas putida SKG-1 isolate. Microb Cell Fact (2011) 0.80
Direct vs. indirect pathway for nitrobenzene reduction reaction on a Ni catalyst surface: a density functional study. Phys Chem Chem Phys (2014) 0.79
Synthesis, characterization and in vitro anti-invasive activity screening of polyphenolic and heterocyclic compounds. Bioorg Med Chem (2003) 0.79
A novel RBP-J kappa-dependent switch from C/EBP beta to C/EBP zeta at the C/EBP binding site on the C-reactive protein promoter. J Immunol (2007) 0.78
Type of opioids injected: does it matter? A multicentric cross-sectional study of people who inject drugs. Drug Alcohol Rev (2014) 0.78
Paenisporosarcina indica sp. nov., a psychrophilic bacterium from a glacier, and reclassification of Sporosarcina antarctica Yu et al., 2008 as Paenisporosarcina antarctica comb. nov. and emended description of the genus Paenisporosarcina. Int J Syst Evol Microbiol (2013) 0.77
DNA-binding behavior of ruthenium(II) complexes containing both group 15 donors and 2,2':6',2''-terpyridine. J Inorg Biochem (2005) 0.77
Novel benzimidazole analogs as inhibitors of EGFR tyrosine kinase. Chem Biol Drug Des (2012) 0.76
Leukocyte Dectin-1 expression is differentially regulated in fungal versus polymicrobial sepsis. Crit Care Med (2009) 0.76
Room-temperature chemoselective reduction of nitro groups using non-noble metal nanocatalysts in water. Inorg Chem (2014) 0.76
Insect-specific irreversible inhibitors of acetylcholinesterase in pests including the bed bug, the eastern yellowjacket, German and American cockroaches, and the confused flour beetle. Chem Biol Interact (2010) 0.76
A preclinical study demonstrating the efficacy of nilotinib in inhibiting the growth of pediatric high-grade glioma. J Neurooncol (2015) 0.76
Computational analysis of C-reactive protein for assessment of molecular dynamics and interaction properties. Cell Biochem Biophys (2013) 0.76
Ruthenium(II) polypyridyl complexes: potential precursors, metalloligands, and topo II inhibitors. Inorg Chem (2008) 0.75
Growth inhibitory, apoptotic and anti-inflammatory activities displayed by a novel modified triterpenoid, cyano enone of methyl boswellates. J Biosci (2011) 0.75
Chemical modifications of natural triterpenes - glycyrrhetinic and boswellic acids: evaluation of their biological activity. Tetrahedron (2008) 0.75
Diagnostic dilemma: A case of self-injurious behavior. Indian J Psychiatry (2011) 0.75
A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients. J Neurosurg Anesthesiol (2017) 0.75
Response. J Neurosurg (2014) 0.75
The Willgerodt-Kindler reaction on lupenone: unusual oxidative dimerization. Nat Prod Lett (2002) 0.75
139 Clinically Applicable and Biologically Validated MRI Radiomic Test Method Predicts Glioblastoma Genomic Landscape and Survival. Neurosurgery (2016) 0.75
Direct synthesis of esters and amides from unprotected hydroxyaromatic and -aliphatic carboxylic acids. J Org Chem (2006) 0.75
Ruthenium-Catalyzed Oxidative Homocoupling of Arylboronic Acids in Water: Ligand Tuned Reactivity and Mechanistic Study. Inorg Chem (2016) 0.75
India's National Narcotic Drugs and Psychotropic Substances policy, 2012: a 20th century document in the 21st century. Int J Drug Policy (2013) 0.75
Rosai-Dorfman disease in an Asian Indian woman with classic generalized lymphadenopathy and nasal obstruction: a case report. Ear Nose Throat J (2009) 0.75
A new thermophilic species of Conidiobolus from India. Mycopathologia (2008) 0.75
Synthesis and in vitro evaluation of N-aryl pyrido-quinazolines derivatives as potent epidermal growth factor receptor inhibitors. Chem Biol Drug Des (2013) 0.75
Troponate/Aminotroponate Ruthenium-Arene Complexes: Synthesis, Structure, and Ligand-Tuned Mechanistic Pathway for Direct C-H Bond Arylation with Aryl Chlorides in Water. Inorg Chem (2016) 0.75
Diffusion Weighted Magnetic Resonance Imaging Radiophenotypes and Associated Molecular Pathways in Glioblastoma. Neurosurgery (2016) 0.75
Novel synthesis of bicycles with fused pyrrole, indole, oxazole, and imidazole rings. J Org Chem (2004) 0.75